Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




New Treatment Options for Attention-Deficit/Hyperactivity Disorder (ADHD): Part II. Guanfacine
Link ID 8480
Title New Treatment Options for Attention-Deficit/Hyperactivity Disorder (ADHD): Part II. Guanfacine
Url http://www.medscape.com/viewarticle/578747?src=rss
Description A new extended-release formulation of guanfacine is currently under review by the FDA specifically for the treatment of ADHD in children between 6 and 17 years of age.
Pediatric Pharmacotherapy
Category Articles > Psychiatry and Mental Health
Keywords
Date Sep 7, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Psychiatry and Mental Health
1. Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
  Psychopharmacology Bulletin
Category:   Articles > Psychiatry and Mental Health


2. Managing ADHD in an Adult With Psychiatric Comorbidity
  This 41-year old man had symptoms of ADHD since first grade, but was never diagnosed. Could earlier diagnosis and treatment have improved his complicated path through adulthood? Medscape Psychiatry & Mental Health
Category:   Articles > Psychiatry and Mental Health


3. Adolescent Neurological Development and its Implications for Adolescent Substance Use Prevention
  How does adolescent neurological development affect their decision-making and behavior? Can this information help develop more appropriate interventions for preventing adolescent substance use?
The Journal of Primary Prevention
Category:   Articles > Psychiatry and Mental Health


4. Dysphagia: Epidemiology, Risk Factors and Impact on Quality of Life -- A Population-based Study
  What is the prevalence of dysphagia among adults aged 18 years and older? Which psychological conditions and risk factors are related to dysphagia? How does dysphagia affect quality of life?
Alimentary Pharmacology & Therapeutics
Category:   Articles > Psychiatry and Mental Health


5. Cognitive Dysfunction in MS: Bridging the Gap Between Neurocognitive Deficits, Neuropsychological Ba
  This review details advances in recognizing and predicting cognitive dysfunction in multiple sclerosis.
Future Neurology
Category:   Articles > Psychiatry and Mental Health




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS